Wanlei Yang
Zhongxing North Road
Shaoxing, 312000, China
Shaoxing, 312000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
High burden of vitamin D deficiency in Chinese university students: impact of sun protection culture.
Journal: Frontiers in nutrition
Published: May 24, 2026
Genetics and pathophysiology of diffuse idiopathic skeletal hyperostosis.
Journal: Frontiers in endocrinology
Published: November 13, 2025
Irisolidone enhances osteoblast differentiation via the AMPK-ULK1-autophagy Axis to accelerate osteoporotic fracture repair.
Journal: Biochemical pharmacology
Published: April 20, 2025
Roles of myokines in osteoporosis under physiological and diabetic conditions.
Journal: Frontiers in endocrinology
Published: March 26, 2025
Velutin Inhibits IL-1β-Induced Nucleus Pulposus Inflammatory and Extracellular Matrix Degradation Attenuating Mouse Intervertebral Disc Degeneration via the NF-κB and MAPK Pathways.
Journal: Mediators of inflammation
Published: March 10, 2025
Erratum to "Activating transcriptional coactivator with PDZ-binding motif by (R)-PFI-2 attenuates osteoclastogenesis and prevents ovariectomized-induced osteoporosis" [Biochem. Pharmacol. 219 (2024) 115964].
Journal: Biochemical pharmacology
Published: December 05, 2024
Mendelian randomization studies of risk and protective factors for osteoporosis: a systematic review and meta-analysis.
Journal: Frontiers in endocrinology
Published: August 25, 2024
Role of YAP/TAZ in bone diseases: A transductor from mechanics to biology.
Journal: Journal of orthopaedic translation
Published: August 01, 2024
Targeted inhibition of STAT3 (Tyr705) by xanthatin alleviates osteoarthritis progression through the NF-κB signaling pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 13, 2023
Activating transcriptional coactivator with PDZ-binding motif by (R)-PFI-2 attenuates osteoclastogenesis and prevents ovariectomized-induced osteoporosis.
Journal: Biochemical pharmacology
Published: August 26, 2023
Activation of TAZ by XMU-MP-1 inhibits osteoclastogenesis and attenuates ovariectomy-induced cancellous bone loss.
Journal: Biochemical and biophysical research communications
Published: August 26, 2023
Last Updated: 09/26/2026